Dr. Jeffrey L. Cummings (Brain Health) co-authored a recently published article titled, "Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders," which addresses new strategies -- particularly involving computational mechanisms -- for discovering new candidates for drug repurposing; legislative, scientific, and regulatory strategies to address intellectual property issues; and how repurposing drug development plays an important role in the drug development ecosystem.
